TickerFactsScreenerDevelopers

DiaMedica Therapeutics Inc. (DMAC) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2017: $22.0K2018: $50.0K2019: $2.0K2020: $47.0K2021: $22.0K2022: $81.0K2023: $24.0K2024: $25.0K2025: $40.0K$40.0K
2017Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$40.0K+60.0%
2024$25.0K+4.2%
2023$24.0K-70.4%
2022$81.0K+268.2%
2021$22.0K-53.2%
2020$47.0K+2250.0%
2019$2.0K-96.0%
2018$50.0K+127.3%
2017$22.0K—